For instance, the level of irisin is significantly lower in patients with obesity, osteoporosis/fractures, muscle atrophy, Alzheimer’s disease, and cardiovascular diseases (CVDs) but higher in patients with cancer. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.